165 related articles for article (PubMed ID: 37511427)
1. Sexual Dimorphism of Skeletal Muscle in a Mouse Model of Breast Cancer: A Functional and Molecular Analysis.
Rentz LE; Whetsell MA; Clayton SA; Mizener AD; Holásková I; Chapa MG; Hoblitzell EH; Eubank TD; Pistilli EE
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511427
[TBL] [Abstract][Full Text] [Related]
2. Sexual Dimorphism of Skeletal Muscle in a Mouse Model of Breast Cancer: A Functional and Molecular Analysis.
Rentz LE; Whetsell M; Clayton SA; Mizener AD; Holásková I; Chapa MG; Hoblitzell EH; Eubank TD; Pistilli EE
bioRxiv; 2023 Jun; ():. PubMed ID: 37362158
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue.
Bohlen J; McLaughlin SL; Hazard-Jenkins H; Infante AM; Montgomery C; Davis M; Pistilli EE
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):701-714. PubMed ID: 29582584
[TBL] [Abstract][Full Text] [Related]
4. The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males.
Morena da Silva F; Lim S; Cabrera AR; Schrems ER; Jones RG; Rosa-Caldwell ME; Washington TA; Murach KA; Greene NP
BMC Genomics; 2023 Jul; 24(1):374. PubMed ID: 37403010
[TBL] [Abstract][Full Text] [Related]
5. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
[TBL] [Abstract][Full Text] [Related]
6. Females display relatively preserved muscle quality compared with males during the onset and early stages of C26-induced cancer cachexia.
Cabrera AR; Deaver JW; Lim S; Morena da Silva F; Schrems ER; Saling LW; Tsitkanou S; Rosa-Caldwell ME; Wiggs MP; Washington TA; Greene NP
J Appl Physiol (1985); 2023 Sep; 135(3):655-672. PubMed ID: 37535708
[TBL] [Abstract][Full Text] [Related]
7. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
8. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in skeletal muscle revealed through fiber type, capillarity, and transcriptomics profiling in mice.
O'Reilly J; Ono-Moore KD; Chintapalli SV; Rutkowsky JM; Tolentino T; Lloyd KCK; Olfert IM; Adams SH
Physiol Rep; 2021 Sep; 9(18):e15031. PubMed ID: 34545692
[TBL] [Abstract][Full Text] [Related]
10. A novel orthotopic mouse model replicates human lung cancer cachexia.
van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
[TBL] [Abstract][Full Text] [Related]
11. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle function during the progression of cancer cachexia in the male Apc
VanderVeen BN; Hardee JP; Fix DK; Carson JA
J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle wasting: the estrogen side of sexual dimorphism.
McMillin SL; Minchew EC; Lowe DA; Spangenburg EE
Am J Physiol Cell Physiol; 2022 Jan; 322(1):C24-C37. PubMed ID: 34788147
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in skeletal muscle alterations in a model of colorectal cancer.
Greenman AC; Albrecht DM; Halberg RB; Diffee GM
Physiol Rep; 2020 Mar; 8(5):e14391. PubMed ID: 32170841
[TBL] [Abstract][Full Text] [Related]
15. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
Dis Model Mech; 2012 Jul; 5(4):533-45. PubMed ID: 22563056
[TBL] [Abstract][Full Text] [Related]
16. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.
Constantinou C; Fontes de Oliveira CC; Mintzopoulos D; Busquets S; He J; Kesarwani M; Mindrinos M; Rahme LG; Argilés JM; Tzika AA
Int J Mol Med; 2011 Jan; 27(1):15-24. PubMed ID: 21069263
[TBL] [Abstract][Full Text] [Related]
17. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
[TBL] [Abstract][Full Text] [Related]
18. IGF1 does not overcome sexual dimorphism of body and muscle size in Mstn-/- mice.
Paul R; Whiteman K; Falconer SJ; Oldham JM; Jeanplong F; Matthews KG; Smith HK; Thomas M; Watson T; McMahon CD
J Endocrinol; 2021 Feb; 248(2):207-220. PubMed ID: 33295877
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
Conte E; Camerino GM; Mele A; De Bellis M; Pierno S; Rana F; Fonzino A; Caloiero R; Rizzi L; Bresciani E; Ben Haj Salah K; Fehrentz JA; Martinez J; Giustino A; Mariggiò MA; Coluccia M; Tricarico D; Lograno MD; De Luca A; Torsello A; Conte D; Liantonio A
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):386-404. PubMed ID: 28294567
[TBL] [Abstract][Full Text] [Related]
20. Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia.
Wyart E; Hsu MY; Sartori R; Mina E; Rausch V; Pierobon ES; Mezzanotte M; Pezzini C; Bindels LB; Lauria A; Penna F; Hirsch E; Martini M; Mazzone M; Roetto A; Geninatti Crich S; Prenen H; Sandri M; Menga A; Porporato PE
EMBO Rep; 2022 Apr; 23(4):e53746. PubMed ID: 35199910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
